ArticleBMC cardiovascular disorders2025
A predictive nomogram for intramyocardial hemorrhage in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention based on coronary angiography-derived index of microcirculatory resistance.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundIntramyocardial hemorrhage (IMH) after ST-segment elevation myocardial infarction (STEMI) reperfusion increases the risk of major adverse cardiovascular events (MACE). We aimed to integrate a coronary angiography-derived index of microcirculatory resistance (caIMR) with clinical features in a nomogram model for predicting IMH in patients with STEMI following primary percutaneous coronary intervention (PCI).
methodsA retrospective study included 309 STEMI patients admitted at Xuzhou Medical University for primary PCI from 2022 to 2023 in training and validation cohorts. Their caIMR was calculated from coronary angiography images and IMH was assessed by cardiac Magnetic Resonance (CMR). A nomogram was constructed through logistic regression analyses. Predictive accuracy, calibration, and clinical usefulness were validated by an area under the curve (AUC) of the receiver operating characteristic (ROC) curve, calibration curves, and decision curve analysis (DCA), respectively. All statistical tests were two-sided.
resultsA total of 247 patients were assigned to the training cohort and 62 to the validation cohort randomly. A nomogram was established using two independent predictors of IMH derived from multivariable analysis: caIMR and left ventricular ejection fraction (LVEF). The AUC for the nomogram was 0.844 (95% confidence interval (CI): 0.793-0.896) in the training cohort and 0.834 (95% CI: 0.724-0.944) in the validation cohort. The predicted and actual estimates were significantly correlated in both cohorts, indicating good calibration of the nomogram. The nomogram was clinically useful for the prediction of IMH, within a 10-88% and 10-74% threshold probability in the training and validation cohorts respectively, exhibited by DCA. Furthermore, the nomogram showed superior discriminative ability for MACE prediction compared to CMR-confirmed IMH (AUC 0.726 vs. 0.584, P < 0.001).
conclusionsThis novel caIMR-based nomogram resulted in high accuracy of prediction for IMH and MACE in STEMI patients undergoing primary PCI. It may become a convenient tool to predict IMH immediately after the PCI procedure, and help with prognostic judgment and early clinical intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.